Presentation is loading. Please wait.

Presentation is loading. Please wait.

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.

Published byBranden Walters Modified over 8 years ago

Similar presentations

Presentation on theme: "ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results."— Presentation transcript:

1 ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

2 ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

3 ELTR 12/2008 EUROPEAN LIVER TRANSPLANT REGISTRY 25 countries - 143 institutions 85,446 transplantations - 76,818 patients 05/1968 - 12/2008 693 2149 4076 921 752 13701 12864 12785 371 583 10831 11 1866 653 1346 1500 174111 14992 1996 1372 1370 16 25 8

4 ELTR 12/2008 Evolution of 85,446 Liver Transplantations in Europe 7 10 7536 4 22 15 25 49 82 84 166 295 544 834 1280 1720 2111 2508 2762 3000 3330 3629 3757 4038 4266 4587 4821 4945 5142 5095 5421 5475 5487 5624 4196 6870727476788082848688909294969820002002200420062008

5 ELTR 12/2008 Evolution of the number of Liver Transplantations reported to the ELTR

6 ELTR 12/2008 Evolution of the number of Liver Transplantations by Center

7 ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

8 ELTR 12/2008 Graft Survival according to Donor Age in Europe 01/1988 - 12/2008

9 ELTR 12/2008 Graft Survival according to Donor Age in Elective Liver Transplantation 01/1988 – 12/2008

10 ELTR 12/2008 Graft Survival according to Donor Age in Urgent Liver Transplantation 01/1988 - 12/2008

11 ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

12 ELTR 12/2008 Evolution of Recipient Age 05/1968 – 12/2008

13 ELTR 12/2008 Patient Survival according to Recipient Age 01/1988 - 12/2008

14 ELTR 12/2008 Patient Survival according to Adult Recipient Age 01/1988 - 12/2008

15 ELTR 12/2008 Proportion of Pediatric Transplantation by Country 01/1988 - 12/2008

16 ELTR 12/2008 Primary Indication of Liver Transplantation in Pediatric Patients 05/1968 - 12/2008

17 ELTR 12/2008 Graft Survival according to Children Recipient Age 01/1988 - 12/2008

18 ELTR 12/2008 Survival of Children >= 2 yrs according to the Main Indication in Europe 01/1988 - 12/2008

19 ELTR 12/2008 Graft Survival according to Adult Recipient Age 01/1988 - 12/2008

20 ELTR 12/2008 Primary Indications of Liver Transplantion in Elderly Patients (>= 60 Years) 01/1988 - 12/2008

21 ELTR 12/2008 Survival of Elderly Recipients (>= 60 Years) according to the Main Indication in Europe 01/1988 - 12/2008

22 ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

23 ELTR 12/2008 * Others :Budd Chiari : 675 Benign liver tumors or Polycystic diseases : 934 Parasitic diseases : 67 Other liver diseases : 533 Primary Diseases leading to Liver Transplantion in Europe 01/1988 - 12/2008

24 ELTR 12/2008 Primary Indications of Liver Transplantion in Europe 01/1988 - 12/2008

25 ELTR 12/2008 Evolution of Primary Diseases leading to Liver Transplantation in Europe 05/1968 - 12/2008

26 ELTR 12/2008 Primary Diseases leading to Liver Transplantion by Country 01/1988 - 12/2008

27 ELTR 12/2008 Primary Diseases leading to Liver Transplantation in Adult Recipients 01/1988 - 12/2008

28 ELTR 12/2008 Patient and Graft Survival following Liver Transplantation 05/1968 – 12/2008

29 ELTR 12/2008 Patient Survival according to the Year of Liver Transplantation

30 ELTR 12/2008 Patient Survival according to the Indication 01/1988 - 12/2008

31 ELTR 12/2008 Patient Survival according to the 1st Indication 01/1988 – 12/2008

32 ELTR 12/2008 Graft Survival according to the Urgency of Liver Transplantation in Europe 01/1988 - 12/2008

33 ELTR 12/2008 Graft Survival according to ABO Compatibility In Elective Liver Transplantation 01/1988 - 12/2008

34 ELTR 12/2008 Graft Survival according to ABO Compatibility In Urgent Liver Transplantation 01/1988 - 12/2008

35 ELTR 12/2008 Liver Transplantation in Europe Indications in 41696 Cirrhosis 01/1988 - 12/2008

36 ELTR 12/2008 Evolution of Indications for Cirrhosis in Europe 05/1968 - 12/2008

37 ELTR 12/2008 Survival of Patients with Cirrhosis as the First Indication 01/1988 - 12/2008

38 ELTR 12/2008 Primary Indications of Liver Transplantation in 15936 Virus related Cirrhosis in Europe 01/1988 - 12/2008

39 ELTR 12/2008 Survival of Patients with Virus related Cirrhosis as the First Indication 01/1988 - 12/2008

40 ELTR 12/2008 Survival of Patients with Virus related Cirrhosis as the First Indication 01/1988 - 12/2008

41 ELTR 12/2008 Survival of Patients with Virus related Cirrhosis as the First Indication 01/1988 - 12/2008

42 ELTR 12/2008 Liver Transplantation in Europe Indications in 10199 Hepato-Biliary Cancers 01/1988 - 12/2008

43 ELTR 12/2008 Evolution of Indications for Hepato-Biliary Cancers in Europe 05/1968 - 12/2008

44 ELTR 12/2008 Survival of Patients with Liver Cancer as the First Indication 01/1988 - 12/2008

45 ELTR 12/2008 Survival of Patients with HCC with and without underlying Cirrhosis 01/1988 - 12/2008

46 ELTR 12/2008 Primary Indications of Liver Transplantation in 6155 Patients with Acute Hepatic Failure 01/1988 - 12/2008

47 ELTR 12/2008 Survival of Patients with Acute Hepatic Failure as the First Indication 01/1988 - 12/2008

48 ELTR 12/2008 Primary Indications of Liver Transplantation in 7552 Patients with Cholestatic Diseases 01/1988 - 12/2008

49 ELTR 12/2008 Survival of Patients with Cholestatic Diseases as the First Indication 01/1988 - 12/2008

50 ELTR 12/2008 Primary Indications of Liver Transplantation in 4542 Patients with Metabolic Diseases 01/1988 - 12/2008

51 ELTR 12/2008 Survival of Patients with Metabolic Diseases as the First Indication 01/1988 - 12/2008

52 ELTR 12/2008 Indications of Liver Transplantation in 2183 Other liver diseases in Europe 05/1968 - 12/2008

53 ELTR 12/2008 Survival of Patients with Other Liver Diseases as the First Indication 01/1988 - 12/2008

54 ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

55 ELTR 12/2008 Graft Survival in Liver Transplantation only vs Liver Combined to other Organ Transplantation 01/1988 - 12/2008

56 ELTR 12/2008 Graft Survival according to the Site of Transplantation in Elective LT 01/1988 - 12/2008

57 ELTR 12/2008 Type of Liver Graft in Europe according to the Date of Transplantation

58 ELTR 12/2008 Graft Survival according to the Type of Graft 01/1988 - 12/2008

59 ELTR 12/2008 Graft Survival according to the Type of Graft 01/1988 - 12/2008

60 ELTR 12/2008 Graft Survival according to the Type of Graft in Elective Liver Transplantation 01/1988 - 12/2008

61 ELTR 12/2008 Graft Survival according to the Type of Graft in Urgent Liver Transplantation 01/1988 - 12/2008

62 ELTR 12/2008 Graft Survival according to the Cold Ischemic Time in UW Elective Liver Transplantation 01/1988 - 12/2008

63 ELTR 12/2008 Graft Survival according to the Cold Ischemic Time in UW Urgent Liver Transplantation 01/1988 - 12/2008

64 ELTR 12/2008 Auxiliary vs Non Auxiliary Graft Survival in Elective Liver Transplantation 01/1988 - 12/2008

65 ELTR 12/2008 Auxiliary vs Non Auxiliary Graft Survival in Urgent Liver Transplantation 01/1988 - 12/2008

66 ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

67 ELTR 12/2008 Liver Transplantation in Europe Mortality and Retransplantation 01/1988 - 12/2008

68 ELTR 12/2008 Graft Survival according to the Number of Liver Transplantations in Europe 01/1988 - 12/2008

69 ELTR 12/2008 Graft Survival according to the number of the Liver Transplantation in Elective Cases 01/1988 - 12/2008

70 ELTR 12/2008 Graft Survival according to the number of the Liver Transplantation in Urgent Cases 01/1988 - 12/2008

71 ELTR 12/2008 Patient Survival according to the number of Liver Transplantations 01/1988 - 12/2008

72 ELTR 12/2008 Patient Survival according to the number of LTs in Elective cases for the 1st LT 01/1988 - 12/2008

73 ELTR 12/2008 Patient Survival according to the number of LTs in Urgent cases for the 1st LT 01/1988 – 12/2008

74 ELTR 12/2008 Mortality following the 1st LT 01/1988 - 12/2008

75 ELTR 12/2008 Causes of Retransplant following the 1st LT 01/1988 - 12/2008

Download ppt "ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results."

Similar presentations

HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant. 2010 Oct; 29 (10): 1083-1141.

HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26: 796-807.

HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.

USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.

Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2010 CIBMTR Summary Slides SUM10_1.ppt.

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2010 CIBMTR Summary Slides SUM10_1.ppt.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2011 Summary Slides Worldwide SUM-WW11_1.ppt.

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2011 Summary Slides Worldwide SUM-WW11_1.ppt.
Optimizing lung transplant outcomes in the adult and pediatric patient. Cynthia S. Herrington, MD Associate Professor of Surgery Keck School of Medicine.

Optimizing lung transplant outcomes in the adult and pediatric patient. Cynthia S. Herrington, MD Associate Professor of Surgery Keck School of Medicine.
HEART-LUNG TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095.

HEART-LUNG TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
ESRD Prognosis 1998-2005 ERA-EDTA vs. Danish Renal Registry James Heaf.

ESRD Prognosis ERA-EDTA vs. Danish Renal Registry James Heaf.
Heart Transplantation for Patients with a Fontan Procedure

Heart Transplantation for Patients with a Fontan Procedure
© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,

© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,
Liver Transplantation Philip Goodney, MD June 22, 2005.

Liver Transplantation Philip Goodney, MD June 22, 2005.
Table 4.1.1: Stock and Flow of Liver Transplantation, 1993-2006 Year93949596*979899000102**03040506 New transplant patients11813328351051658 Deaths00341041251443.

Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant. 2012 Oct; 31(10): 1045-1095.

LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
CHAPTER 4 LIVER TRANSPLANTATION Editors: Dr Ganesalingam A/L Kanagasabai Expert panel: Dr Ganesalingam A/L Kanagasabai (Chairperson) Professor Dr Lee Way.

CHAPTER 4 LIVER TRANSPLANTATION Editors: Dr Ganesalingam A/L Kanagasabai Expert panel: Dr Ganesalingam A/L Kanagasabai (Chairperson) Professor Dr Lee Way.
Living Donor Liver Transplantation in PSC Patients Giuliano Testa, MD, FACS, MBA Surgical Director, Living Donor Liver Transplantation Baylor University.

Living Donor Liver Transplantation in PSC Patients Giuliano Testa, MD, FACS, MBA Surgical Director, Living Donor Liver Transplantation Baylor University.
PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA 1998-2009 Bisigniano Liliana MD., López-Rivera Arturo.

PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo.
12/2013 The Present Evolution of Liver Transplantation in Europe EUROPEAN LIVER TRANSPLANT REGISTRY 28 countries - 155 institutions 118,441 transplantations.

12/2013 The Present Evolution of Liver Transplantation in Europe EUROPEAN LIVER TRANSPLANT REGISTRY 28 countries institutions 118,441 transplantations.
Table 4.1.1: Stock and Flow of Liver Transplantation, 1993-2005 Year 93949596*979899000102**030405 New transplant patients 1181332835105165 Deaths 0034104125144.

Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths
Liver Transplantation

Liver Transplantation

Similar presentations

Ads by Google